EMA Expired: Maci (autologous cultured chondrocytes) — Vericel Denmark ApS

View source ↗

Summary

The EMA has expired the Maci (autologous cultured chondrocytes) product license from Vericel Denmark ApS, affecting its use for fractures and cartilage repair.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cartilage Injury
• Fractures
• Osteochondral Defect

Drugs mentioned

• MACI (matrix-induced autologous chondrocyte implantation)

Snippet

Status: Expired. Therapeutic area: Fractures, Cartilage. MAH: Vericel Denmark ApS. Decision date: 01/07/2018